Repligen Corporation
RGEN
$130.13
$4.803.83%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -1.85% | 4.82% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -1.85% | 4.82% | |||
| Cost of Revenue | -8.62% | 6.56% | |||
| Gross Profit | 4.29% | 3.30% | |||
| SG&A Expenses | 2.92% | 0.95% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -2.53% | 3.09% | |||
| Operating Income | 5.76% | 28.96% | |||
| Income Before Tax | -90.73% | 11.69% | |||
| Income Tax Expenses | -212.62% | 164.70% | |||
| Earnings from Continuing Operations | -37.28% | -10.89% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -37.28% | -10.89% | |||
| EBIT | 5.76% | 28.96% | |||
| EBITDA | 2.07% | 11.05% | |||
| EPS Basic | -37.33% | -10.94% | |||
| Normalized Basic EPS | -4.10% | 35.63% | |||
| EPS Diluted | -35.72% | -11.50% | |||
| Normalized Diluted EPS | -4.07% | 35.45% | |||
| Average Basic Shares Outstanding | 0.08% | 0.08% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.22% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||